FGL2 expression and relation with survival and prognosis in patients treated with concurrent temozolamide and radiotherapy in high-grade glioma.

被引：0
|
作者：
Elnaggar, Maha
Mohamed, Mohamed Alaa
Makboul, Rania
El Hakeem, Ahmed A. S.
El-Ghani, Wael M. A. Abd
Essam, Sohaila Mohammed
Eid, Samir-Shehata M.
机构：
[1] Assiut Univ, Fac Med, Assiut, Egypt
[2] Al Azhar Univ, Fac Med, Assiut, Egypt
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14019
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Patterns of Failure Following Concurrent Bevacizumab and Hypofractionated Stereotactic Radiotherapy for Recurrent High-grade Glioma
    Shapiro, L. Q.
    Karimi, S.
    Gutin, P. H.
    Iwamoto, F. M.
    Zhang, Z.
    Lassman, A. B.
    Abrey, L. E.
    Beal, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S125 - S125
  • [22] Prospective Study of Concurrent Erlotinib and Radiotherapy (RT): Pattern of Failure for Pediatric High-Grade Glioma
    Panandiker, A. S. Pai
    Merchant, T. E.
    Sharma, S.
    Qaddoumi, I.
    Gajjar, A.
    Broniscer, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S587 - S588
  • [23] Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations
    Chaskis, Cristo
    Neyns, Bart
    Michotte, Alex
    De Ridder, Mark
    Everaert, Hendrik
    [J]. SURGICAL NEUROLOGY, 2009, 72 (04): : 423 - 428
  • [24] Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
    Tabouret, Emeline
    Boudouresque, Francoise
    Barrie, Maryline
    Matta, Mona
    Boucard, Celine
    Loundou, Anderson
    Carpentier, Antoine
    Sanson, Marc
    Metellus, Philippe
    Figarella-Branger, Dominique
    Ouafik, L'Houcine
    Chinot, Olivier
    [J]. NEURO-ONCOLOGY, 2014, 16 (03) : 392 - 399
  • [25] Safety of concurrent bevacizumab therapy and anticoagulation in high-grade glioma patients.
    Bartolomeo, J.
    Norden, A. D.
    Drappatz, J.
    Ciampa, A. S.
    Doherty, L. M.
    LaFrankie, D. C.
    Quant, E. C.
    Beroukhim, R.
    Wen, P. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) TREATED WITH BEVACIZUMAB
    Ye, L.
    Hasani, A.
    Nowak, A.
    King, A.
    Long, A.
    Trevenen, M.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 72 - 72
  • [27] The prognostic value of cognitive functioning in the survival of patients with high-grade glioma
    Klein, M
    Postma, TJ
    Taphoorn, MJB
    Aaronson, NK
    Vandertop, WP
    Muller, M
    van der Ploeg, HM
    Heimans, JJ
    [J]. NEUROLOGY, 2003, 61 (12) : 1796 - 1798
  • [28] Survival prediction of high-grade glioma patients with diffusion kurtosis imaging
    Zhang, Ju
    Jiang, Jingjing
    Zhao, Lingyun
    Zhang, Jiaxuan
    Shen, Nanxi
    Li, Shihui
    Guo, Linying
    Su, Changliang
    Jiang, Rifeng
    Zhu, Wenzhen
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3680 - 3688
  • [29] High-grade glioma treated with 3d external beam radiotherapy (3DCRT) and sterotactic radiotherapy combined with concurrent temozolomide and carboplatin
    Garran, C.
    Aristu, J.
    Moreno, M.
    Nagore, G.
    Valero, J.
    Santisteban, M.
    Fernandez-Hidalgo, O.
    Guridi, J.
    Manrique, M.
    Martinez-Monge, R.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 138 - 138
  • [30] The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma
    Kleinberg, L
    Grossman, SA
    Piantadosi, S
    Zeltzman, M
    Wharam, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 535 - 543
12345